tiprankstipranks
Trending News
More News >

Activist Parvus building stake in Novo Nordisk, FT reports

London-based activist hedge fund Parvus Asset Management is building a stake in Novo Nordisk (NVO) as the Ozempic-maker hunts for a new CEO following a share price slump, people with knowledge of the matter told Financial Times’ Oliver Barnes and Hannah Kuchler. The hedge fund wants to influence the appointment of Novo Nordisk’s new Chief Executive, the report stated.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

1